✦ LIBER ✦

Comparison of ticagrelor, the first reversible oral P2Y12 receptor antagonist, with clopidogrel in patients with acute coronary syndromes: Rationale, design, and baseline characteristics of the PLATelet inhibition and patient Outcomes (PLATO) trial

✍ Scribed by Stefan James; Axel Åkerblom; Christopher P. Cannon; Håkan Emanuelsson; Steen Husted; Hugo Katus; Allan Skene; Philippe Gabriel Steg; Robert F. Storey; Robert Harrington; Richard Becker; Lars Wallentin

Book ID: 117981128
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 139 KB
Volume: 157
Category: Article
ISSN: 1097-6744
DOI: 10.1016/j.ahj.2009.01.003

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Comparison of ticagrelor, the first reve

Comparison of ticagrelor, the first reversible oral P2Y12 receptor antagonist, with clopidogrel in patients with acute coronary syndromes: Rationale, design, and baseline characteristics of the PLATelet inhibition and patient Outcomes (PLATO) trial

✍ Stefan James; Axel Åkerblom; Christopher P. Cannon; Håkan Emanuelsson; Steen Hus 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 139 KB

Prior smoking status, clinical outcomes,

Prior smoking status, clinical outcomes, and the comparison of ticagrelor with clopidogrel in acute coronary syndromes—Insights from the PLATelet inhibition and patient Outcomes (PLATO) trial

✍ Jan H. Cornel; Richard C. Becker; Shaun G. Goodman; Steen Husted; Hugo Katus; An 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 435 KB

PRIOR SMOKING STATUS, CLINICAL OUTCOMES,

PRIOR SMOKING STATUS, CLINICAL OUTCOMES, AND THE COMPARISON OF TICAGRELOR WITH CLOPIDOGREL IN ACUTE CORONARY SYNDROMES – INSIGHTS FROM THE PLATELET INHIBITION AND PATIENT OUTCOMES (PLATO) TRIAL

✍ Jan Hein Cornel; Richard Becker; Shaun Goodman; Steen Husted; Hugo Katus; Anwar 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 219 KB

Inhibitory Effects of Ticagrelor Compare

Inhibitory Effects of Ticagrelor Compared With Clopidogrel on Platelet Function in Patients With Acute Coronary Syndromes: The PLATO (PLATelet inhibition and patient Outcomes) PLATELET Substudy

✍ Robert F. Storey; Dominick J. Angiolillo; Shankar B. Patil; Bhaloo Desai; Rosema 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 916 KB

Inhibition of Platelet Aggregation by AZ

Inhibition of Platelet Aggregation by AZD6140, A Reversible Oral P2Y12 Receptor Antagonist, Compared With Clopidogrel in Patients With Acute Coronary Syndromes

✍ Robert F. Storey; Steen Husted; Robert A. Harrington; Stanley Heptinstall; Rober 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 797 KB

Safety, Tolerability, and Initial Effica

Safety, Tolerability, and Initial Efficacy of AZD6140, the First Reversible Oral Adenosine Diphosphate Receptor Antagonist, Compared With Clopidogrel, in Patients With Non–ST-Segment Elevation Acute Coronary Syndrome: Primary Results of the DISPERSE-2 Trial

✍ Christopher P. Cannon; Steen Husted; Robert A. Harrington; Benjamin M. Scirica; 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 215 KB